Section 1.1 paragraph 4

[ManonGros]

Proposed reworking of this paragraph by @birgitgemeinholzer:

It does not express any view on the issue of the sharing of benefits arising from access to digital sequence information, the subject of extensive discussion through the Convention on Biological Diversity [https://www.cbd.int/abs/] (CBD), but refers to extensive documentation that has been incorporated into sequence data generation. However, it is worth noting that genetic barcodes and metabarcodes are typically short fragments of non-coding or coding genes, which are not suitable for commercial exploitation. As the archiving of sequences through International Nucleotide Sequence Database Collaboration (INDSC) [http://www.insdc.org/] widely accepted standard in sequence-based research, the publication of occurrence data is only additional information to the sequences available in the public genetic repository.

In addition to that, two comments concerning the last sentence of the paragraph:

Therefore, the added value of publishing sequence-derived data relates to spatio-temporal occurrences and sequence-based names, and not to the genetic information itself.

• Comment 1: you want to use the genetic information itself, which is deposited in the genbanks and add additional information to it
• Comment 2: I would like to point out that added value can be created by adding metadata to the sequences

[CecSve]

Maybe this one is for you @dschigel ?

[dschigel]

Yes, I will need to think about it. will take care of. Somehow linked to #30

[dschigel]

1. Add "but refers to documentation that has been incorporated into sequence data generation." in the suggested space.

[dschigel]

agreed that guide works as is